CD8A and neoplasm: Correspondingly, we observed significant HLA-I-dependent tumor killing by LDH assay upon coculturing RCAN1-422-32-primed CD8+ T cells with SF10360 (RCAN1-4pos GBM cells) (Fig. 3H, Supplementary Fig. 7A, B).